Copyright © 1997 by the European Society of Cardiology.
© 1997 The European Society of Cardiology
Myocardial viability
Stress echocardiography vs nuclear medicine

* Department of Cardiology Medicine, University Hospital Liège, Belgium
Nuclear Medicine, University Hospital Liège, Belgium
Correspondence: Prof. Luc A. Piérard, FESC, CHU Sart Tilman—Cardiology, B-4000 Liège, Belgium
Myocardial dyssynergy does not necessarily indicate myocardial necrosis in patients with coronary artery disease. The differentiation between viable and non-viable tissue is of great clinical importance in order to make the most appropriate clinical decision in the individual patient. Several techniques are used to assess myocardial viability. Nuclear medicine gives reliable information on regional perfusion, metabolism and cell membrane integrity, while echocardiography provides real time visualization of myocardial thickening in basal conditions and continuously during pharmacological interventions. The presence or absence of contractile reserve in akinetic regions can be evaluated by pharmacological stress echocardiography.
This article presents the semiology of myocardial viability as characterized by these different methods and reviews their relative value in different clinical settings.
Key Words: Dobutamine echocardiography heart failure myocardial infarction positron emission tomography scintigraphy viability